NCT05016011View on ClinicalTrials.gov

Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

March 21, 2022

Study Completion Date

March 21, 2022

Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL

Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)

Human umbilical cord-derived mesenchymal stem cells

PROCEDURE

Marrow cellution

Patients will undergo marrow cellution surgical procedure.

Trial Locations (1)

56000

Hospital Canselor Tuanku Muhriz Universiti Kebangsaan Malaysia (HCTM-UKM), Bandar Tun Razak

All Listed Sponsors
collaborator

Universiti Kebangsaan Malaysia Medical Centre

OTHER

lead

Cytopeutics Sdn. Bhd.

INDUSTRY

NCT05016011 - Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury | Biotech Hunter | Biotech Hunter